Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
Inactivation of calicivirusesRaymond Nims, Mark PlavsicBiologicals : Journal of the International Association of Biological Standardization|November 3, 2012
Polyomavirus inactivation - a reviewRaymond W Nims, Mark PlavsicBiologicals : Journal of the International Association of Biological Standardization|August 30, 2011
Gamma irradiation of animal sera for inactivation of viruses and mollicutes--a reviewRaymond W Nims, Gay Gauvin, Mark PlavsicBiologicals : Journal of the International Association of Biological Standardization|September 19, 2016
Vesivirus 2117: Cell line infectivity range and effectiveness of amplification of a potential adventitious agent in cell culture used for biological productionMark Plavsic, Klaudia Shick, Katherine F Bergmann, et al.PDA Journal of Pharmaceutical Science and Technology|December 6, 2014
Detection of adventitious agents using next-generation sequencingBrenda Richards, Sherry Cao, Mark Plavsic, et al.Biotechnology and Bioengineering|November 28, 2012
Identification and quantitation of Vesivirus 2117 particles in bioreactor fluids from infected Chinese hamster ovary cell culturesYongchang Qiu, Nathan Jones, Michelle Busch, et al.Molecular Therapy. Methods & Clinical Development|January 8, 2020
AAVrh10 Vector Corrects Disease Pathology in MPS IIIA Mice and Achieves Widespread Distribution of SGSH in Large Animal BrainsMichaël Hocquemiller, Kim M Hemsley, Meghan L Douglass, et al.Nature Biotechnology|April 29, 2020
Viral contamination in biologic manufacture and implications for emerging therapiesPaul W Barone, Michael E Wiebe, James C Leung, et al.Pageof 1